Sorrento Therapeutics Inc. buy melinda
Start price
27.03.19
/
50%
€4.53
Target price
30.10.19
€7.22
Performance (%)
-69.82%
End price
30.10.19
€1.37
Summary
This prediction ended on 30.10.19 with a price of €1.37. Massive losses of -69.82% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sorrento Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
| iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
| iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
| iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
According to melinda what are the pros and cons of Sorrento Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Sorrento Therapeutics Inc. diskutieren
Secteur Recherche biotechnologique et médicale
Sorrento Therapeutics, Inc. est une société biopharmaceutique. Société est engagée dans la découverte, l'acquisition, le développement et la commercialisation de médicaments thérapeutiques. Son principal centre d’intervention thérapeutique est l’oncologie et le traitement de la douleur cancéreuse chronique. Elle développe également des produits thérapeutiques pour d'autres indications, dont l'immunologie et les maladies infectieuses. Cellular Antigen Receptor-T Cell (CAR-T), résineifératoxine (RTX) et programmes de développement clinique d'anticorps biosimilaires / biobetter. Son portefeuille de produits comprend également des anticorps monoclonaux (AcM), thérapies précliniques exclusivement humaines, et comprenant des biosimilaires / biobetters,
Nombre d'employés
: 162 personnes
Stopped prediction by melinda for Sorrento Therapeutics Inc.
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.05
03.01.23
03.01.23
-
03.01.24
03.01.24
-73.34%
28.03.23
28.03.23
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.97
27.12.21
27.12.21
€6.00
27.12.22
27.12.22
-83.85%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.45
16.02.20
16.02.20
€12.00
04.11.21
04.11.21
138.93%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.70
30.12.17
30.12.17
€3.97
02.01.18
02.01.18
10.98%
02.01.18
02.01.18
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.21
12.12.17
12.12.17
€2.62
15.12.17
15.12.17
18.37%
15.12.17
15.12.17
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.45
12.12.17
12.12.17
€2.90
15.12.17
15.12.17
18.37%
15.12.17
15.12.17
Could be worthwhile Investment >10% per year